Scarica l'app Stockscreener
1.42
11.81%
0.15
Pre-mercato:
1.46
0.04
+2.82%
Precedente Chiudi:
$1.27
Aprire:
$1.28
Volume 24 ore:
501.52K
Relative Volume:
2.85
Capitalizzazione di mercato:
$4.11M
Reddito:
$2.49M
Utile/perdita netta:
$-21.46M
Rapporto P/E:
-0.0727
EPS:
-19.526
Flusso di cassa netto:
$-21.50M
1 W Prestazione:
+29.09%
1M Prestazione:
+6.77%
6M Prestazione:
-89.48%
1 anno Prestazione:
-94.38%
Intervallo 1D:
$1.26
$1.48
Intervallo di 1 settimana:
$0.9631
$1.51
Portata 52W:
$0.9631
$34.75
Geovax Labs Inc Stock (GOVX) Company Profile
Nome
Geovax Labs Inc
Settore
Industria
Telefono
678-384-7220
Indirizzo
1955 LAKE PARK DRIVE, SMYRNA
Compare GOVX vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GOVX
Geovax Labs Inc
|
1.42 | 4.11M | 2.49M | -21.46M | -21.50M | -19.53 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Geovax Labs Inc Stock (GOVX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-19 | Downgrade | D. Boral Capital | Buy → Hold |
| 2025-04-15 | Reiterato | Alliance Global Partners | Buy |
| 2025-04-15 | Reiterato | D. Boral Capital | Buy |
| 2024-11-11 | Iniziato | Alliance Global Partners | Buy |
| 2024-07-16 | Iniziato | ROTH MKM | Buy |
| 2020-11-19 | Iniziato | Maxim Group | Buy |
Mostra tutto
Geovax Labs Inc Borsa (GOVX) Ultime notizie
$GeoVax Labs (GOVX.US)$ Thanks for the spike last week! I be back... - Moomoo
GOVX Forecast, Price Target & Analyst Ratings | GEOVAX LABS INC (NASDAQ:GOVX) - ChartMill
GeoVax Advances Gedeptin Toward Phase 2 Trials and Seeks Partnership Opportunities - citybuzz -
GeoVax Advances Gedeptin(R) Toward Phase 2 Initiation and Strategic Partnership Opportunities - Yahoo Finance
GOVX Technical Analysis | Trend, Signals & Chart Patterns | GEOVAX LABS INC (NASDAQ:GOVX) - ChartMill
GeoVax Labs Inc expected to post a loss of $4.42 a shareEarnings Preview - TradingView
GeoVax Positions Gedeptin as Immune-Sensitizing Platform Amid Rising Investment in In Vivo Cancer Therapies - citybuzz -
Large warrant share approvals headline GeoVax (GOVX) 2026 proxy and annual meeting - Stock Titan
GeoVax Highlights Gedeptin(R) as a Potential Immune-Sensitizing Platform Amid Rising Industry Investment in In Vivo Cancer Therapies - Yahoo Finance
GOVX Stock Chart | GEOVAX LABS INC (NASDAQ:GOVX) - ChartMill
[EFFECT] GeoVax Labs, Inc. SEC Filing - Stock Titan
GOVX SEC FilingsGeovax Labs Inc 10-K, 10-Q, 8-K Forms - Stock Titan
GeoVax Labs (NASDAQ: GOVX) adds auditor consent in S-1 amendment - Stock Titan
[POS EX] GeoVax Labs, Inc. SEC Filing - Stock Titan
GeoVax Labs (GOVX) adds auditor consent to S-1; lists private placement exercisable shares - Stock Titan
GeoVax Labs (NASDAQ: GOVX) seeks votes to approve Feb/March 2026 warrant exercises - Stock Titan
GOVX Maintained by D. Boral Capital -- Price Target Steady at $1 - GuruFocus
GeoVax Labs (GOVX) Stock vs Peers (Edges Lower) 2026-04-16Scalping - Xã Thanh Hà
GeoVax Labs, Inc. Files Form 8-K with Nasdaq: Company Details, Financial Highlights, and Key Disclosures - Minichart
GeoVax Labs, Inc. 2024 Annual Report: Clinical Pipeline, Business Overview, Risks, and Intellectual Property Strategies - Minichart
GeoVax Reports 2025 Year-End Financial Results and Provides Business Update - National Today
GeoVax Labs (NASDAQ: GOVX) resale of 2.27M warrant shares, no issuer proceeds - Stock Titan
GeoVax Labs (NASDAQ: GOVX) investors face going concern, dilution risks - Stock Titan
GeoVax Advances Mpox/Smallpox Vaccine Toward Phase 3 Trial Amid Global Supply Concerns - citybuzz -
Form 8-KCurrent report - ADVFN
GeoVax Labs Inc reports results for the quarter ended December 31Earnings Summary - TradingView
GeoVax Labs (NASDAQ: GOVX) details vaccine pipeline and flags going concern risk - Stock Titan
GeoVax Labs, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
How The GeoVax Labs (GOVX) Story Is Shifting After The Rating Downgrade And Valuation Reset - Yahoo Finance
GeoVax Positions GEO-MVA to Address Supply Constraints in Global Mpox and Smallpox Vaccine Market - Yahoo Finance
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) - ADVFN
Amended Statement of Ownership (sc 13g/a) - ADVFN
Post-effective Amendment to Registration Statement (pos Am) - ADVFN
Annual Report (10-k) - ADVFN
Quarterly Report (10-q) - ADVFN
Form 10-QQuarterly report [Sections 13 or 15(d)] - ADVFN
Forecast Cut: What is the long term forecast for GeoVax Labs Inc Equity Warrant stock2026 WrapUp & Smart Swing Trading Techniques - baoquankhu1.vn
GOVX|GeoVax Labs Inc|Price:1.230|Chg%:0.07 - TradingKey
Noble Financial Maintains GeoVax Labs(GOVX.US) With Buy Rating, Cuts Target Price to $10 - Moomoo
12 Health Care Stocks Moving In Wednesday's After-Market Session - Sahm
Movement Recap: How much upside does GeoVax Labs Inc Equity Warrant have2026 Technicals & Short-Term Swing Trade Alerts - baoquankhu1.vn
Published on: 2026-04-09 02:29:52 - baoquankhu1.vn
Gains Report: What is the long term forecast for GeoVax Labs Inc Equity Warrant stockRate Cut & Intraday High Probability Alerts - baoquankhu1.vn
Momentum Shift: What is GeoVax Labs Incs valuation compared to sectorWeekly Market Summary & Growth Oriented Trading Recommendations - baoquankhu1.vn
GeoVax Highlights Single-Dose Mpox Vaccine Data at World Vaccine Congress 2026 - Yahoo Finance
Geovax Labs Inc (E8LA.MU) Stock Price, News, Quote & History - Yahoo! Finance Canada
GeoVax Labs Delays Annual 10-K Filing - The Globe and Mail
GeoVax Labs Boosts Liquidity Through Warrant Inducement Financing - TipRanks
GeoVax Secures $863,000 Through Warrant Inducement Transaction to Fund Vaccine and Immunotherapy Development - citybuzz -
[8-K] GeoVax Labs, Inc. Reports Material Event - Stock Titan
[NT 10-K] GeoVax Labs, Inc. SEC Filing - Stock Titan
Geovax Labs Inc Azioni (GOVX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.14%
0.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):